CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Selling, general and administrative (Q2 2026) | YoY |
|---|---|
| $104M | +58.8% |
| Selling, general and administrative (Q2 2026) | $104M |
|---|---|
| YoY | +58.8% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| Q2 2026 | $104M | +58.8% |
| Q1 2026 | $105M | +82.8% |
| Q2 2025 | $66M | — |
| Q1 2025 | $57M | — |